Reperfusion Injury  >>  cyclosporine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
CAPRI, NCT02390674: Ciclosporin to Reduce Reperfusion Injury in Primary PCI

Completed
2
54
Europe
Ciclosporin, Sandimmun, Saline
Newcastle-upon-Tyne Hospitals NHS Trust, National Institute for Health Research, United Kingdom, Newcastle University
Myocardial Reperfusion Injury
04/17
11/17
2014-002628-29: Ciclosporin to reduce damage to the heart during routine treatment for a heart attack (CAPRI)

Not yet recruiting
2
68
Europe
N/A, N/A, Concentrate for solution for infusion, Sandimmun (concentrate for solution for infusion 50mg/ml)
Newcastle upon Tyne Hospitals NHS Foundation Trust, NIHR Newcastle Biomedical Research Centre
Myocardial ischemia/reperfusion injury, Heart attack, Diseases [C] - Cardiovascular Diseases [C14]
 
 

Download Options